Last week, Ukraine’s law officially legalising medical cannabis came into effect, eight months after initially being passed. Despite the positive progress, the list of diseases for which it will be prescribed, currently being decided upon by the Ministry of Health, does not yet include Post-Traumatic Stress [...]

An incident on board a British Airways flight has sparked further calls for police and other organisations to be better informed of medical cannabis laws. The British Airways flight travelling from London City Airport to Amsterdam on 28 June, was grounded for hours by armed police [...]

A recent survey has found that over a third of patients with Parkinson’s disease are turning to natural remedies, including cannabis, coffee and turmeric, to help manage their symptoms.  The study, published in the Journal of Parkinson’s, also revealed that a large number of these patients [...]

Earlier this month, the Philippine House of Representatives voted overwhelmingly in favour of a bill that would legalise medical cannabis, marking a significant step forward for cannabis liberalisation in Southeast Asia. House Bill 10439, which was initially submitted in May, 2024, received its third and final [...]

A new study highlights how cannabis can be a helpful tool for reducing opioid use and providing ‘rapid relief’ from symptoms of withdrawal. The study, which received funding from the National Institute of Drug Abuse (NIDA), comes following a surge in overdose mortality rates over the [...]

Written by Releaf To establish whether medical cannabis is the right option for you, you need to know whether it’s within your budget. Here, Releaf breaks down how much it all costs and the different plans available. Market research has shown that one of the most [...]

Blue Light Card holders, including emergency service workers and health and social care staff can now access medical cannabis at a reduced cost, following the expansion of a UK initiative. Medical cannabis distributor, Grow Pharma, has announced the expansion of its access scheme, the Grow Access [...]

As the UK medical cannabis industry reaches a ‘tipping point’, experts are urging clinics to follow best practice guidelines, as regulators look to crackdown on what has been described as a ‘pseudo-recreational market’.  Health and social care watchdog, the Care Quality Commission (CQC) recently reported a [...]

The independent drug policy foundation, Transform, is fundraising to launch a national campaign to accelerate cannabis reform in the UK. The charity is hoping to raise £50,000 to support its work in bringing “responsible cannabis regulation” to the UK. Polls show that more than half of [...]

Written by Releaf With medical cannabis showing promise among elderly patients, UK cannabis clinic, Releaf, examines its efficacy, safety profile, and other things to consider when exploring this treatment option for yourself or a loved one. Since medical cannabis was legalised in the UK almost six [...]

Germany’s Federal Joint Committee (G-BA) has proposed significant changes to the medical cannabis prescription process, set to have a major impact on the country’s already booming market. Germany’s private or ‘self funded’ medical cannabis market has exploded since the introduction of CanG on April 01, which [...]

Minor cannabinoids CBG, CBC, CBN, and CBDV have shown promise as anti-cancer agents in the treatment of blood cancer. Cannabinoids are now widely prescribed to palliative cancer patients to help manage symptoms, as well as the side-effects of conventional treatments such as chemotherapy.  They have also [...]

The UK’s Food Standards Agency (FSA) has issued its first positive safety assessment for a consortium application in its CBD Novel Foods approval process, seeing the European Industrial Hemp Association’s (EIHA) RP427 application progress to the ‘risk management’ phase. Coming just months after the first two [...]

In one of the first human trials investigating CBG, the cannabinoid has shown promise in reducing anxiety and enhancing memory, without any negative side-effects. Alongside CBD and THC, cannabigerol (CBG) is thought to have its own therapeutic effects, including potential anti-anxiety and antidepressant benefits, although the [...]

The Czech government looks to be pursuing a full commercial adult-use cannabis market as part of its ‘Cannabis Management Act’, according to leaked documents seen by Business of Cannabis.  It came just days after the architect and driving force behind the cannabis legalisation project, National Drug Coordinator [...]

Six months on from the opening of Europe’s first legal cannabis stores in Switzerland, experts are reporting trends towards regulated sales and ‘lower-risk’ consumption methods, such as edibles and extracts. The first data collected from the Grashaus Project in the canton of Basel-Landschaft, which launched at [...]

Three years ago the toppling of a conservative Government in Germany led to a seminal moment for European cannabis – but there appears to be little chance of a repeat in the continent’s second most populous nation. The UK General Election has seen the Labour Party [...]

While CBD is generally considered to be safe, new animal studies have shown alterations in brains and behaviour in offspring exposed to the cannabinoid during pregnancy. The International Cannabis Policy Study recently reported that one in five pregnant women may be using CBD products, believing that [...]

Experts examine how Medical Cannabis may have the potential to improve the quality of life for individuals with Muscular Dystrophy. The article is an excerpt from Cannabiscientia’s handbook, Principles of Clinical Cannabinology, by Viola Brugnatelli and Fabio Turco. Muscular dystrophy (MD) brings a unique set of [...]

As legal cannabis becomes increasingly available across Europe, the first commercial brainwave analysis device is expected to advance understanding of its effects. Canadian AI neurotechnology company, Zentrela, announced the launch of its brainwave analysis device on the European market at the end of June. The Cognalyzer® [...]

UK life sciences company, Ananda Developments, has announced that its CBD-based drug demonstrated “cardioprotective effects” in a pre-clinical study and may hold promise as a potential treatment for heart failure.  The company recently shared results from preclinical studies investigating the efficacy of its Patent Pending formulation, [...]

Cannaray Limited, its medical cannabis subsidiary Therismos, and Canadian ‘aquaponics’ cannabis cultivator Aqualitas are set to merge to create a new international vertically integrated cannabis company. Officially launching at Cannabis Europa this week, the newly combined entity, which reportedly saw combined sales of £40m last year, [...]

A new study suggests that adults aged 65 and older experience “considerable improvements” in their health and wellbeing when prescribed cannabis-based medicines. The use of medical cannabis is said to be on the rise among older individuals, yet little research has been done to understand the [...]

A pilot scheme introducing the legal sale and production of cannabis in the Netherlands is due to be expanded to eight more cities across the country. In December 2023, the Dutch government embarked on a pilot scheme to regulate the production of cannabis to supply the country’s  ‘coffeeshops’. [...]

A new research paper has highlighted how many people are still accessing cannabis illegally for medicinal purposes in the UK, over five years on from the law change. Despite medical cannabis being legalised in the UK in 2018, previous reports indicate that a large number of [...]

Script Assist has announced that its medical cannabis technology platform, which aims to enable an efficient medical cannabis journey for clinics, doctors and patients, will be available on a software as a service (SaaS) basis for the first time. With its platform now expanding from a [...]

Lyphe is proud to announce the launch of its new low-cost medical cannabis line, Noidecs Vital, designed to address affordability issues for medical patients. Recognising the financial barriers many patients face in accessing cannabis treatments, the Noidecs Vital line will provide a cost-effective option that does [...]

One in six patients in primary care reported cannabis use, with most using it to manage a symptom or health condition, according to new research. The findings, to be published in JAMA Network Open, by researchers at UCLA, suggest that most patients reported using cannabis for symptom [...]